Management of common clinical problems experienced by survivors of cancer
Improvements in early detection and treatment have led to a growing prevalence of survivors
of cancer worldwide. Models of care fail to address adequately the breadth of physical …
of cancer worldwide. Models of care fail to address adequately the breadth of physical …
Comorbid depression in medical diseases
SM Gold, O Köhler-Forsberg, R Moss-Morris… - Nature Reviews …, 2020 - nature.com
Depression is one of the most common comorbidities of many chronic medical diseases
including cancer and cardiovascular, metabolic, inflammatory and neurological disorders …
including cancer and cardiovascular, metabolic, inflammatory and neurological disorders …
[HTML][HTML] Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority
Background A cancer diagnosis can have a substantial impact on mental health and
wellbeing. Depression and anxiety may hinder cancer treatment and recovery, as well as …
wellbeing. Depression and anxiety may hinder cancer treatment and recovery, as well as …
Distress management, version 3.2019, NCCN clinical practice guidelines in oncology
MB Riba, KA Donovan, B Andersen, II Braun… - Journal of the National …, 2019 - jnccn.org
Distress is defined in the NCCN Guidelines for Distress Management as a multifactorial,
unpleasant experience of a psychologic (ie, cognitive, behavioral, emotional), social …
unpleasant experience of a psychologic (ie, cognitive, behavioral, emotional), social …
Suicide risk and mortality among patients with cancer
M Heinrich, L Hofmann, H Baurecht, PM Kreuzer… - Nature medicine, 2022 - nature.com
Despite substantial progress in cancer therapy in recent decades, patients with cancer
remain at high suicide risk. Data from individual studies have not been comprehensively …
remain at high suicide risk. Data from individual studies have not been comprehensively …
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
S Ross, A Bossis, J Guss… - Journal of …, 2016 - journals.sagepub.com
Background: Clinically significant anxiety and depression are common in patients with
cancer, and are associated with poor psychiatric and medical outcomes. Historical and …
cancer, and are associated with poor psychiatric and medical outcomes. Historical and …
Classical psychedelics for the treatment of depression and anxiety: A systematic review
S Muttoni, M Ardissino, C John - Journal of affective disorders, 2019 - Elsevier
Background Depression and anxiety are prevalent psychiatric disorders that carry significant
morbidity. Pharmacological and psychosocial interventions are used to manage these …
morbidity. Pharmacological and psychosocial interventions are used to manage these …
Management of anxiety and depression in adult survivors of cancer: ASCO guideline update
BL Andersen, C Lacchetti, K Ashing… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To update the American Society of Clinical Oncology guideline on the
management of anxiety and depression in adult cancer survivors. METHODS A …
management of anxiety and depression in adult cancer survivors. METHODS A …
Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review
N Schimmers, JJ Breeksema, SY Smith-Apeldoorn… - …, 2022 - Springer
Background Terminally ill patients may experience existential distress, depression, or
anxiety, limiting quality of life in the final stage. Existing psychotherapeutic or …
anxiety, limiting quality of life in the final stage. Existing psychotherapeutic or …
[HTML][HTML] Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
Rationale Major depressive disorder is one of the leading global causes of disability, for
which the classic serotonergic psychedelics have recently reemerged as a potential …
which the classic serotonergic psychedelics have recently reemerged as a potential …